Pulse Intravenous Methylprednisolone for Resistant Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis

Allergic bronchopulmonary aspergillosis (ABPA) results from a hypersensitivity response to Aspergillus fumigatus. It is seen in a number of chronic respiratory conditions, particularly in association with cystic fibrosis (CF). Oral corticosteroids and itraconazole represent the mainstay of treatment...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric pulmonology 2006-02, Vol.41 (2), p.164-170
Hauptverfasser:	Thomson, Janine M., Wesley, Alison, Byrnes, Catherine A., Nixon, Gillian M.
Format:	Artikel
Sprache:	eng
Schlagworte:	allergic bronchopulmonary aspergillosis Antifungal Agents - therapeutic use Aspergillosis, Allergic Bronchopulmonary - complications Aspergillosis, Allergic Bronchopulmonary - drug therapy Aspergillus - drug effects Aspergillus - isolation & purification Biological and medical sciences Child children corticosteroid cystic fibrosis Cystic Fibrosis - complications Cystic Fibrosis - drug therapy Drug Resistance, Fungal Errors of metabolism Female Follow-Up Studies Glucocorticoids - administration & dosage Glucocorticoids - therapeutic use Human mycoses Humans Infant Infectious diseases Injections, Intravenous Itraconazole - therapeutic use Male Medical sciences Metabolic diseases methylprednisolone Methylprednisolone - administration & dosage Methylprednisolone - therapeutic use Miscellaneous hereditary metabolic disorders Miscellaneous mycoses Mycoses Pneumology pulse therapy Pulse Therapy, Drug Sputum - microbiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!